Guizhou Sanli Pharmaceutical Co.,Ltd Stock: price and insider trades · China
三力制药
Guizhou Sanli Pharmaceutical Co.,Ltd: what insiders have been doing
This page follows insider dealings at Guizhou Sanli Pharmaceutical Co.,Ltd as filed with SSE / SZSE (CSRC), a company from the Health Care sector. The past year has been quiet: not a single insider filing for Guizhou Sanli Pharmaceutical Co.,Ltd. The previous disclosure was published on 4 July 2025.
Since 2022, the database holds no purchases and 6 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 39,350 shares100.0% of flowA股XSHGSSE:173000009168672930
- 620,200 shares16.3% of flowA股XSHGSSE:173000006608942940
- 999,910 shares26.5% of flowA股XSHGSSE:173000006604719070
- 950,000 shares26.4% of flowA股XSHGSSE:173000006564492380
- 701,371 shares14.7% of flowA股XSHGSSE:173000005278197440
- 784,800 shares16.2% of flowA股XSHGSSE:173000005250145730
6 of 6 declarations
About Guizhou Sanli Pharmaceutical Co.,Ltd
Sanli Pharmaceutical is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and production of innovative medicines.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
